No Detail Found!

Secretome of hypoxia-preconditioned mesenchymal stem cells promotes liver regeneration and anti-fibrotic effect in liverfibrosis animal model

Author(s)
Farid Amansyah, Department of Postgraduate Medical Science, Faculty of Medicine, Hasanuddin University, Kota Makassar, Sulawesi Selatan 90245, Indonesia
B. Budu Department of Postgraduate Medical Science, Faculty of Medicine, Hasanuddin University, Kota Makassar, Sulawesi Selatan 90245, Indonesia; Department of Ophthalmology, Faculty of Medicine, Hasanuddin University, Kota Makassar, Sulawesi Selatan 90245, Indonesia
Muhammad Harun Achmad Department of Pedodontic, Faculty of Dentistry, Hasanuddin University, Kota Makassar, Sulawesi Selatan 90245, Indonesia
Nu'man AS. Daud, Department of Internal Medicine, Faculty of Medicine, Hasanuddin University, Kota Makassar, Sulawesi Selatan 90245, Indonesia
Agung Putra Department of Stem Cell and Cancer Research, Faculty of Medicine, Sultan Agung Islamic University, Kota Semarang Jawa Tengah 50112, Indonesia;Department of Postgraduate Biomedical Science, Faculty of Medicine, Sultan Agung Islamic University, Kota Semarang,Jawa Tengah 50112, Indonesia;Department of Pathological Anatomy, Faculty of Medicine, Sultan Agung Islamic University, Kota Semarang, Jawa Teng
Muhammad Nasrum Massi Department of Microbiology, Faculty of Medicine, Hasanuddin University, Kota Makassar, Sulawesi Selatan 90245, Indonesia
Agussalim Bukhari Department of Nutritional Sciences, Faculty of Medicine, Hasanuddin University, Kota Makassar, Sulawesi Selatan 90245, Indonesia
Marhaen Hardjo Department of Biomedicine, Faculty of Medicine, Hasanuddin University, Kota Makassar, Sulawesi Selatan 90245, Indonesia; 'Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Kota Makassar, Sulawesi Selatan 90245, Indonesia
Luthfi Parewangi Department of Internal Medicine, Faculty of Medicine, Hasanuddin University, Kota Makassar, Sulawesi Selatan 90245, Indonesia
llhamjaya Patellongi Department of Biostatistics, Faculty of Public Health, Hasanuddin University, Kota Makassar, Sulawesi Selatan 90245, Indonesia
Abstract
Backgrando Oubjnectdive : Liver fibrosis (LF) is a most common pathological process characterized by the activation of hepatocytes leading to the accumulation of extracellular matrix (ECM). Hypoxia precondition treated in MSCs (H-MSCs) could enhance their immunomodulatory and regeneration capability, through expressing robust anti-inflammatory cytokines and growth factors, known as H-MSCs secretome (SH-MSCs) that are critical for the improvement of liver fibrosis. However, the study regarding the efficacy and mechanism of action of SH-MSCs in ameliorating liver fibrosis s still inconclusive. In this study, the therapeutic potential and underlying mechanism for SH-MSCs in the treatment of liver fibrosis were investigated. Materials and Methods: A rat model with liver fibrosis induced by CCl, was created and maintained for 8 weeks. The rats received intravenous doses of SH-MSCs and secretome derived from normoxia MSCs (SN-MSCs), filtered using a tangential flow filtration (TFF) system with different molecular weight cut-off categories, both ata dosage of 0.5 mL. The ELISA assay was employed to examine the cytokines and growth factors present in both SH-MSCs and SN-MSCs. On the ninth day, the rats were euthanized and liver tissues were collected for subsequent histological examination and analysis of mRNA expression. Results: The ELISA test revealed that SH-MSCs exhibited higher levels of VEGF, PDGF, bFGF, IL-10, TGF-B and IL-6 compared to SN-MSCs. /n vivo, administration of SH-MSCs notably decreased mortality rates. It also demonstrated a reduction in liver fibrosis, collagen fiber areas, a-SMA positive staining and relative mRNA expression of TGF-B. Conversely, SN-MSCsalso contributedto liver fibrosisimprovement, although SH-MSCs demonstrated more favorable outcomes. Conclusion: Currentfindings suggested that SH-MSCs could improve CCl,-induced liver fibrosis and decrease a-SMA and TGF-B expression.
Publication Details
Page(s) 18-26
Published Journal: Pakistan Journal of Biological Sciences, Volume: 27, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Liver fibrosis, collagen, Mesenchymal stem cells, Sectetome, CCI
References
Dis Semin. Liver . .. , 37 : 1-10.
Sun M.,Kisseleva T. .2015 .Reversibility ofliver fibrosis. , : .
Hepatol Clin. Res. . .. , 39 : S60-563.
Venturi C,Bourdeaux C.,Hoyos S.P. .2014 .Dynamofialclogsraft fibrosis in pediatric liver transplantation. Am. J. Transpl., 14 : 1648-1656.
Hermansyah D,K. D .2021 .Mesenchymal stem cells suppress TGF-B release to decrease a-SMA expression in ameliorating CCl4-inldiveur cfiebrodsis. Med, 75 : 16-22.
Sungkar T,Putra A.,D. A. .2020 .Lindarto and RJ. , : .
T. ,Putra A.,D. A.,Garcia-Sanchez D.,Fernandez D.,Rodriguez-Rey J.C.,Pérez-Campo F.M.,Y. F.M.,Tsuchiya A.,Ogawa M.,Nojiri S.,Takeuchi S.,D.M. S.,Munir D.,Putra D. .2022 .Revealing the decrease of indoleamine 2,3-dioxygenase as a major constituent for B cells survival post-mesenchymal stem cells co-cultured with peripheral blood mononuclear cells (PBMC) of systemic lupus erythematosus (SLE) patients. Medicinski Glasnik, 19 : 1414-21.
. Drawina P,Putra A.,Nasihun T.,Prajoko Y.W.,Dirja B.T.,Amalina N.D. .2022 .Increased serial levels of platelet-derived growth factor using hypoxic mesenchymal stem cell-conditioned medium to promote closure acceler-ationin a full-thickness wound. Indones. J. Biotechnol, 27 : 36-42.
. Putra A,Alif I,Hamra N.,Santosa O.,Lukman K. .2020 .MSC-released TGF-B regulate a-SMA expression of myofibroblast during wound healing. J. Stem Cells Regener. Med, 16 : 73-79.
Kwon B.S. .2017 .Differentiation potential of mesenchymal stem cells is related to their intrinsic mechanical properties. Int. Neurourol.J., 21 : 524-31.
. Restimulia L,Ghaissani S.S.,Haryono E. .2022 .Downregulation of IL-6 and TNF-a expression with mesenchymal stem cells therapy inallergicrhinitriasts models. Int.J. Cell Biomed. Sci, 1 : 27-34.
NF ,Putra A.,Tjipta A,Amalina N.D.,Nasihun T. .2021 .Hypoxia mesenchymal stem cells accelerate wound closure improvement by controlling a-smooth muscle actin expression in the full-thickness animal model. Open Access Maced. J. Med. Sci., 9 : 35-41.
YW ,Amalina N.D. .2022 .The ameliorating effects of MSCs in controlling treg-mediated B-cell depletion byindoleamine2, 3-dioxygenase induction in PBMC of SLE patients. Open Access Maced. J. Med. Sci., 10 : 6-11.
. Chacko S.,Selvendiran K.,Kuppusamy M.L.,Khan M.,Kuppusamy P. .2010 .Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am. J. Physiol. Cell Physiol, 299 : C1562-C1570.
Yao Y.,Xia Z. .2021 .Human placental mesenchymal stem cells ameli olivrerafitbreosis in mice by upregulation of Caveolin1 in hepatic stellate cells. He et a/, : .
Stem Cell Res. Ther. . .. , 12 : 513287.
Rong X,Yao X.,Jiang T.,Wang Y.,Xie F. .2019 .. , : .
. .Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/B-catenin pathway. Stem Cell Res. Ther, 10 : .
M.A ,Subchan P.,Handoyo F.E.,Husain S.A. .2022 .Topical gel of mesenchymal stem cell-conditioned medium-induced serum injury accelerates wound healing in skin excision tissue. Int.J. Cell Biomed. Sci., 1 : 10-17.
Putra A,Widyatmoko A.,Ibrahim S.,Amansyah F.,Amansyah F. .2021 .Case series of the first three severe COVID-19 patients treated with the secretome of hypoxia-mesenchymal ~ stem cells in Indonesia.. , : .
. .. F1000Research, 10 : .
Putra A,Pasongka Z,Widyatmoko A.,Prasetio A.,Dirja B.T. .2022 .X-ray scanning reduce soluble active mole cofumeslenechysmal stem cells. In tJ. .Cell Biomed. Sci., 1 : 35-40.
Zhang ,D. Zhou J.,Li X.,Yan J.,Zhu J. .2019 .Effects ofbone marrow-derived mesenchymal stem cells on hypoxia and the transforming growth factor beta 1 (TGFB-1) and SMADs pathway in a mouse model of cirrhosis. Med, : .
Monit . .. , 25 : 7182-7190.
Huang B.,Wang W. .2016 .Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. J. Transl. Med, 14 : 512967.
Liu S.C.,Hung W.C.,Chen H.,Zhang H. .2017 .Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusioninduced lung injury. PLoS ONE, 0187637 : .
Nakamura S.,Mizuno S. .2010 .The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc. Jpn. Acad. Ser. B, 86 : 588-610.
Elpek G.O. .2015 .Angiogenesis and liver fibrosis. World J. Hepatol, 7 : 377-391.
D ,Berthiaume F.,Nahmias Y.,A.W.Tillesand M.L. Yarmush Y. .2008 .Mesenchymal stem cell-derived moleculemsodduliater ehepcattocelllyular death and regeneration /n vitro and in vivo. Hepatology, 47 : 1634-1643.
Zhu Y,Zhang X.,Zhu J.,Zhao Q.,Li Y. .2012 .Cytotoxicity of phenol red in toxicity assays for carbon nanopInta. J. rMol.tScii,Vocl. 1l3.1e0.3s390./ijms131012336., : .
Liu X,Chen B.,Chen L,Ren W.T. .2013 .U-shape suppressive effect of phenol red on the epileptiform burst activity via activation of estrogen receptors in primary hippocampal =~ culture. PLoS ONE, 0060189 : .
Gyorfi AH .2018 .Targeting TGF- signaling for the treatment of fibrosis. Matrix Biol, : 8-27.
Dai H.Y.,Li G.,Ritchie J.X.,Zhou J.X. .2009 .The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res, 2 : 16-25.
0

Citations

0

Downloads

30

Views